Rentokil
193 hedge funds and large institutions have $1.86B invested in Rentokil in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 68 increasing their positions, 73 reducing their positions, and 21 closing their positions.
240% more call options, than puts
Call options by funds: $214K | Put options by funds: $63K
0.05% less ownership
Funds ownership: 2.05% → 1.99% (-0.05%)
7% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 73
3% less funds holding
Funds holding: 199 → 193 (-6)
7% less capital invested
Capital invested by funds: $2.01B → $1.86B (-$148M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$8.38M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$6.26M |
| 3 |
Jane Street
New York
|
+$5.08M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
+$4.45M |
| 5 |
JP Morgan Chase
New York
|
+$3.87M |
Top Sellers
RTO Hedge Fund Activity: Q3 2023 in Review
193 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Rentokil (RTO) for Q3 2023, worth a combined $1.86B — down 7.4% from $2.01B a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of RTO and 15 opened new positions — a net loss of 6 holders — while 73 trimmed existing stakes and 68 added.
The largest buyer was Morgan Stanley, adding an estimated $8.38M. The largest seller was MIG Capital, exiting entirely with an estimated $23.7M sold.
- 193 institutional investors held Rentokil (RTO) as of Q3 2023, down from 199 in Q2 2023.
- Funds reported $1.86B of Rentokil stock for Q3 2023, down 7.4% quarter-over-quarter.
- 15 funds opened new Rentokil positions in Q3 2023 and 21 closed out, a net change of -6 holders.
- The largest Rentokil buyer in Q3 2023 was Morgan Stanley, an estimated $8.38M added.
- The largest Rentokil seller in Q3 2023 was MIG Capital, an estimated $23.7M sold.
Based on aggregated 13F filings for Q3 2023.